论文部分内容阅读
目的:对布地奈德联合特布他林雾化吸入治疗小儿支气管肺炎的临床方法及其疗效进行分析与研究。方法:随机选择2015年7月-2016年7月在我院进行治疗的120例支气管肺炎患儿,其中,对照组60例,观察组60例。对于对照组患儿采用的是常规治疗方法,对于观察组患者是在对照组的基础上使用地奈德联合特布他林雾化吸入治疗,并对两组患儿的治疗效果进行对比。结果:对照组患者总有效率为78.33%,观察组患者总有效率为95%,观察组疗效明显好于对照组,且,P<0.05,具有统计学意义。结论:布地奈德联合特布他林雾化吸入治疗小儿支气管肺炎临床效果显著。
OBJECTIVE: To analyze and study the clinical efficacy of budesonide combined with terbutaline in the treatment of infantile bronchial pneumonia. Methods: A total of 120 children with bronchopneumonia who were treated in our hospital from July 2015 to July 2016 were selected randomly, including 60 in the control group and 60 in the observation group. For the control group of children with conventional treatment, the observation group of patients in the control group based on the use of inhaled debridement combined with terbutaline therapy, and the treatment of children with two groups were compared. Results: The total effective rate of the control group was 78.33%, the total effective rate of the observation group was 95%, the effect of the observation group was significantly better than that of the control group, and P <0.05, with statistical significance. Conclusion: Budesonide combined with Terbutaline nebulization for the treatment of bronchial pneumonia in children is clinically effective.